PDPN and neoplasm: This agent demonstrated the ability to inhibit PDPN-dependent platelet aggregation and PDPN-induced cancer metastasis.98 Although this cancer-specific antibody shows promise as a molecular targeting therapy, PDPN is expressed only on the stromal fibroblasts that surround tumours of the pancreas.